For cancer patients, e-cigarettes not helpful for smoking cessation
the ONA take:
According to a new study published in the journal Cancer, patients with cancer who use e-cigarettes as a form of smoking cessation are equally or less likely to quit smoking compared with those who do not use e-cigarettes. Researchers from Memorial Sloan-Kettering Cancer Center in New York City, New York, sought to examine whether cancer patients using e-cigarettes affect smoking cessation due to the increased use of the device.
In the study, researchers followed 1,074 patients with cancer that smoke who were receiving care at a comprehensive cancer center and also part of a tobacco treatment program between 2012 and 2013. During that time, e-cigarette use rose from 10.6% to 38.5% of patients.
At follow-up, researchers found that the patients using e-cigarettes were equally as likely as non-users to still be smoking cigarettes. Furthermore, patients using e-cigarettes were found to be twice as likely to be regular smokers of cigarettes compared with non-users.
The American Cancer Society does not recommend for or against the the use of e-cigarettes for smoking cessation due to the lack of known and benefits and potential risks associated with long-term use.
Patients with cancer who use e-cigarettes are equally or less likely to quit smoking.
Despite the well-documented risks to health that are posed by smoking, previous research has shown that smoking habits can continue long after a cancer diagnosis has been made. The authors of the new study state that approximately two thirds of smokers diagnosed with cancer continue to do so after diagnosis.
This continuation is problematic, as smoking can cause new mutations among cancer survivors, resulting in secondary or further forms of primary cancer. Smoking can also reduce how effective cancer treatments are.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Patients and Caregivers Worry About Cost of Cancer Care
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- How to Help Patients at the End of Life and Their Loved Ones During the Holidays
- Real-World Prevalence of AEs With Immune Checkpoint Inhibitors for NSCLC Higher Than Reported in Trials
- Disparities Seen in Goals-of-Care Discussions With Minority vs Nonminority Patients
- Acupuncture Eases Some Self-Reported Symptoms of Cancer, Cancer Treatments
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|